— Know what they know.
Not Investment Advice

CANC

Tema Oncology ETF
1W: -1.3% 1M: -7.2% 3M: -1.6% YTD: +18.5% 1Y: +40.4% 3Y: +83.2%
$40.99
-0.31 (-0.76%)
 
Weekly Expected Move ±2.9%
$39 $40 $41 $42 $43
ETF NASDAQ · AUM $130.0M

Portfolio Health Summary

IS Overall Score
51.7
★★★★★
Altman Z-Score
14.67
Safe
Weight Coverage
99%
of portfolio analyzed
Holdings Matched
58
with fundamental data

InsiderStreet Scorecard

★★★★★ 51.7
Profitability
53.3
Balance Sheet
53.0
Earnings Quality
55.1
Growth
56.2
Value
36.9
Momentum
67.0
Safety
76.4

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
14.67
Safe Zone (>2.99)
Piotroski F-Score
4.5 / 9
Moderate
Beneish M-Score
-0.80
Possible Manipulator
Credit Score
—
Earnings Quality
55.1 / 100

Portfolio Valuation

P/E
35.31x
P/B
12.03x
P/S
6.48x
EV/EBITDA
20.58x
EV/Revenue
7.11x
P/FCF
26.27x
P/OCF
21.24x
PEG
2.08x
Earnings Yield
2.83%
FCF Yield
3.81%
OCF Yield
4.71%
Median P/E
-7.98x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +33.2%
Net Income -2.2%
EPS +6.6%
FCF +4.5%
EBITDA +0.6%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +82.7%
Rev CAGR 5Y +19.3%
EPS CAGR 3Y +17.0%
EPS CAGR 5Y +11.4%
FCF CAGR 3Y +18.5%
FCF CAGR 5Y +12.9%
EBITDA CAGR 3Y +13.7%
EBITDA CAGR 5Y +11.7%
Payout Ratio
69.85%
Buyback Yield
0.77%
Dividend Yield
0.74%
Total Shareholder Return
-8.69%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 788 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$40.99
Median 1Y
$43.29
5th Pctile
$6.18
95th Pctile
$302.36
Ann. Volatility
121.2%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 35.31
Portfolio P/B 12.03
Portfolio P/S 6.48
EV/EBITDA 20.58
EV/Revenue 7.11
P/FCF 26.27
P/OCF 21.24
PEG 2.08
Earnings Yield 2.83%
FCF Yield 3.81%
OCF Yield 4.71%
Median P/E -7.98
Profitability & Returns (9)
MetricValue
Gross Margin 75.34%
Operating Margin 27.65%
Net Margin 17.07%
FCF Margin 23.76%
ROE 31.89%
ROA 9.63%
ROIC 20.07%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.32
Debt/Assets 0.39
Net Debt/EBITDA 1.57
Interest Coverage 11.50
Current Ratio 1.22
Quick Ratio 0.98
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 33.19%
Net Income Growth -2.20%
EPS Growth 6.64%
FCF Growth 4.50%
EBITDA Growth 0.61%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 82.69%
Revenue CAGR 5Y 19.27%
Revenue CAGR 10Y —
EPS CAGR 3Y 16.98%
EPS CAGR 5Y 11.44%
EPS CAGR 10Y —
FCF CAGR 3Y 18.54%
FCF CAGR 5Y 12.86%
FCF CAGR 10Y —
EBITDA CAGR 3Y 13.70%
EBITDA CAGR 5Y 11.71%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 14.15%
Net Income CAGR 5Y 9.74%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 51.7
IS Profitability 53.3
IS Balance Sheet 53.0
IS Earnings Quality 55.1
IS Growth 56.2
IS Value 36.9
IS Momentum 67.0
IS Safety 76.4
IS Quality 61.2
Altman Z-Score 14.67
Piotroski F-Score 4.48
Beneish M-Score -0.80
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.74%
Payout Ratio 69.85%
Buyback Yield 0.77%
Total Shareholder Return -8.69%
Growth Stability (4)
MetricValue
Revenue Stability 0.676
Earnings Stability 0.478
Earnings Persistence 0.710
Margin Stability 0.632
Medians (3)
MetricValue
Median P/E -7.98
Median P/B 5.19
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 99.35%
Holdings Matched 58
Total Holdings 58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms